Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Cancer. 2016 Oct 24;123(1):43–51. doi: 10.1002/cncr.30324

Figure 2. Medical oncologists’ recommendations for adjuvant systemic chemotherapy by clinical and recurrence score (RS) testing subgroups.

Figure 2

Distribution (%) of medical oncologists’ chemotherapy recommendations for chemotherapy (for, neutral, against) estimated from multiply-imputed data. Sample sizes reported are weighted and averaged across multiple imputation iterations. Intermed indicates an intermediate RS.